SLRX logo

Salarius Pharmaceuticals (SLRX) Cash From Investing

Annual CFI

$0.00
+$1.50 M+100.00%

December 31, 2023


Summary


Performance

SLRX Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSLRXcash flowmetrics:

Quarterly CFI

N/A

September 30, 2024


Summary


Performance

SLRX Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherSLRXcash flowmetrics:

TTM CFI

N/A

September 30, 2024


Summary


Performance

SLRX TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherSLRXcash flowmetrics:

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

SLRX Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+100.0%--
3 y3 years+100.0%--
5 y5 years-100.0%--

SLRX Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+100.0%
5 y5-year-100.0%+100.0%
alltimeall time-100.0%+100.0%

Salarius Pharmaceuticals Cash From Investing History

DateAnnualQuarterlyTTM
Dec 2023
$0.00(-100.0%)
-
-
Dec 2022
-$1.50 M(<-9900.0%)
$0.00(0.0%)
-$1.50 M(0.0%)
Sep 2022
-
$0.00(0.0%)
-$1.50 M(0.0%)
Jun 2022
-
$0.00(-100.0%)
-$1.50 M(0.0%)
Mar 2022
-
-$1.50 M(<-9900.0%)
-$1.50 M(<-9900.0%)
Dec 2021
$0.00(-100.0%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2021
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2021
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2021
-
$0.00(0.0%)
$0.00(-100.0%)
Dec 2020
-$2600.00(-100.0%)
-
-
Dec 2019
$5.61 M(-60.3%)
$0.00(-100.0%)
$5.61 M(-0.1%)
Sep 2019
-
$5.61 M(>+9900.0%)
$5.61 M(+180.0%)
Mar 2019
-
$0.00(-100.0%)
$2.00 M(-85.8%)
Dec 2018
$14.12 M
$3400.00(>+9900.0%)
$14.12 M(-24.8%)
DateAnnualQuarterlyTTM
Sep 2018
-
$0.00(-100.0%)
$18.78 M(+135.2%)
Jun 2018
-
$2.00 M(-83.5%)
$7.99 M(-73.1%)
Mar 2018
-
$12.12 M(+160.0%)
$29.73 M(+21.4%)
Dec 2017
$24.49 M(-300.1%)
$4.66 M(-143.2%)
$24.49 M(+18.2%)
Sep 2017
-
-$10.80 M(-145.5%)
$20.71 M(-25.1%)
Jun 2017
-
$23.74 M(+245.0%)
$27.64 M(-1603.0%)
Mar 2017
-
$6.88 M(+677.5%)
-$1.84 M(-85.0%)
Dec 2016
-$12.24 M(-55.1%)
$885.00 K(-122.8%)
-$12.24 M(-59.4%)
Sep 2016
-
-$3.87 M(-32.4%)
-$30.16 M(-17.2%)
Jun 2016
-
-$5.73 M(+62.8%)
-$36.44 M(+18.5%)
Mar 2016
-
-$3.52 M(-79.3%)
-$30.76 M(+12.8%)
Dec 2015
-$27.27 M
-$17.04 M(+67.8%)
-$27.27 M(+166.6%)
Sep 2015
-
-$10.15 M(>+9900.0%)
-$10.23 M(>+9900.0%)
Jun 2015
-
-$49.20 K(+86.4%)
-$75.60 K(+186.4%)
Mar 2015
-
-$26.40 K
-$26.40 K

FAQ

  • What is Salarius Pharmaceuticals annual cash flow from investing activities?
  • What is the all time high annual CFI for Salarius Pharmaceuticals?
  • What is Salarius Pharmaceuticals annual CFI year-on-year change?
  • What is the all time high quarterly CFI for Salarius Pharmaceuticals?
  • What is the all time high TTM CFI for Salarius Pharmaceuticals?

What is Salarius Pharmaceuticals annual cash flow from investing activities?

The current annual CFI of SLRX is $0.00

What is the all time high annual CFI for Salarius Pharmaceuticals?

Salarius Pharmaceuticals all-time high annual cash flow from investing activities is $24.49 M

What is Salarius Pharmaceuticals annual CFI year-on-year change?

Over the past year, SLRX annual cash flow from investing activities has changed by +$1.50 M (+100.00%)

What is the all time high quarterly CFI for Salarius Pharmaceuticals?

Salarius Pharmaceuticals all-time high quarterly cash flow from investing activities is $23.74 M

What is the all time high TTM CFI for Salarius Pharmaceuticals?

Salarius Pharmaceuticals all-time high TTM cash flow from investing activities is $29.73 M